Gilead Sciences EuroCharity's RSS for Gilead Sciences en 2010 2nd Tuesday of June 2020 10:16:32 PM 2nd Tuesday of June 2020 10:16:32 PM en 2010 Logo Gilead Sciences: Profiles in Creating Possible - Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships Read the full article here 2020-03-13 16:03:00 15180 2010-03-23T15:57:28Z Treatment With Gilead’s Vesatolimod Is Evaluated for Safety and Virologic and Immunologic Response Versus Placebo in Phase 1B HIV Functional Cure Study Results Presented at CROI 2020 Support Further Evaluation of Vesatolimod as Part of Investigational Curative Regimens Aimed at Achieving ART-Free Control of HIV 2020-03-10 14:03:34 15210 2010-03-23T15:57:28Z Gilead Sciences: Innovation and Growth in Immuno-Oncology Read the article by Daniel O’Day, Chairman and CEO of Gilead 2020-03-05 12:03:05 15136 2010-03-23T15:57:28Z Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19 U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 2020-02-26 14:03:31 15211 2010-03-23T15:57:28Z Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University These investigational agents have potential for use in HIV long-acting therapies for treatment and prevention, as well as cure strategies 2020-01-09 14:03:00 15212 2010-03-23T15:57:28Z